Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anidulafungin plus AmBisome for Invasive Aspergillosis
NCT00037206Phase 3Completed
- Sponsor
- Pfizer
- Start
- May 2002
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of anidulafungin in invasive aspergillosis (IA), sponsored by Pfizer. Started May 2002; status: completed.
02
Drugs
anidulafungin
03
Conditions
invasive aspergillosis (IA)
Beyond the preview
Go deeper on NCT00037206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00037206.